Can buttermilk (ayran) with its postbiotic content be used in the protection of colon health?
Journal of Immunology and Clinical Microbiology · 14.02.2025 · 9 (4) · 127-137
DOI: 10.58854/jicm.1606939 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Immunology and Clinical Microbiology, online erschienen am 14.02.2025. Verfasst von Leyla Tarhan : Çelebi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: yok.
Abstract (Originalsprache)
Objective
In recent years, we have come across articles on the positive effects of nutrition in disease prevention and treatment processes. The microbiota formed by bacteria in the human body can play a role in various diseases and cancer. There is some information on the prevention and treatment of colon cancer by products called postbiotics produced by some bacteria in this flora. It was aimed to investigate the therapeutic effects of ayran, an ingredient rich in postbiotic products, on colon cancer. Materials and Methods: This study evaluates the effects of postbiotic LTW 35 on normal colon fibroblast (CRL-1459) and colon cancer (CCL-224) cell lines. CRL-1459 cells treated with TT X100 for cytotoxicity and CCL-224 cells grown to sufficient density were exposed to normal buttermilk and buttermilk containing 1%, 2%, 3%, and 4% postbiotic LTW 35. Cell viability was assessed using the MTT assay, and tumor activity was measured via the Ca 19-9 tumor marker.
Results
The viability of CRL-1459 colon fibroblast cells decreases progressively with increasing concentrations of TT X100, reaching its lowest level at 0.5%. The viability of colorectal cancer cells is reduced as the concentration of postbiotic LTW 35 (Streptococcus thermophilus ATA-LTC St140700, Bifidobacterium animalis ATA-BSLA0310, Lactobacillus acidophilus ATA-LAP1201 ferment extract lysate) increases, with the lowest viability observed at 4%. Ca19-9 tumor marker levels in cancer cells decrease gradually with increasing concentrations of postbiotic LTW 35, showing the most significant reduction at 4%.
Conclusion
Postbiotic LTW 35-enriched buttermilk restores the viability of TTX 100-damaged normal colon fibroblast cells and reduces the viability of colorectal cancer cells in a concentration-dependent manner, indicating both restorative and anticancer effects. The observed decrease in Ca19-9 tumor marker levels further highlights its potential in reducing tumor activity.
Förderung
- yok
Zitieren
APA
Çelebi, L. T., Bursalıoğlu, E. O., Çakıcı, B., Genel, N., Kalbişen, H. T., & Aslan, İ. (2025). Can buttermilk (ayran) with its postbiotic content be used in the protection of colon health?. Journal of Immunology and Clinical Microbiology, 9(4), 127-137. https://doi.org/10.58854/jicm.1606939
Vancouver
Çelebi LT, Bursalıoğlu EO, Çakıcı B, Genel N, Kalbişen HT, Aslan İ. Can buttermilk (ayran) with its postbiotic content be used in the protection of colon health?. Journal of Immunology and Clinical Microbiology. 2025;9(4):127-137. doi:10.58854/jicm.1606939
BibTeX
@article{elebi2025,
author = {Çelebi, Leyla Tarhan : and Bursalıoğlu, Ertugrul Osman and Çakıcı, Bekir and Genel, Nagihan and Kalbişen, Hasan Tahsin and Aslan, İsmail},
title = {Can buttermilk (ayran) with its postbiotic content be used in the protection of colon health?},
journal = {Journal of Immunology and Clinical Microbiology},
year = {2025},
volume = {9},
number = {4},
pages = {127--137},
doi = {10.58854/jicm.1606939}
}
EUVIMED